• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Williamson Kevin

    9/19/24 6:52:57 PM ET
    $TNON
    Medical/Dental Instruments
    Health Care
    Get the next $TNON alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    Williamson Kevin

    (Last) (First) (Middle)
    104 COOPER COURT

    (Street)
    LOS GATOS CA 95032

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    09/03/2024
    3. Issuer Name and Ticker or Trading Symbol
    Tenon Medical, Inc. [ TNON ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Financial Officer
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    No securities are beneficially owned.
    /s/ Kevin Williamson 09/19/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $TNON alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $TNON

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $TNON
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco

      LOS GATOS, CA / ACCESSWIRE / January 9, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced that Chief Financial Officer Kevin Williamson will host one-on-one investor meetings in San Francisco, CA during the week of January 13th in accordance with the 43rd Annual J.P. Morgan Healthcare Conference.The J.P. Morgan Healthcare Conference is the industry's leading global investment forum, bringing together top executives, investors, and innovators across the healthcare ecosystem. With over 500 healthcare companies presenting, the event showcases groundbreaking advanc

      1/9/25 8:00:00 AM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • Tenon Medical Reports Third Quarter 2024 Financial Results

      ~ 3Q Revenue of $0.9 Million, Consistent with Prior Quarter; Year to Date Revenue of $2.5 Million, Growth of 18.3% Compared to Prior Year ~~ Published Interim Analysis from MAINSAIL™ Study; Post-Market Study Supports the Safety and Efficacy of the Catamaran SI Joint Fusion System® Including Radiographic Proof of Fusion ~~ Initial Clinical Procedures Completed with New Catamaran SE Platform ~~ Granted Issuance of Three U.S. Patents ~~ Received Net Proceeds of ~$9.6 Million from Equity Financing Transactions ~ LOS GATOS, CA / ACCESSWIRE / November 13, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company transforming care for patients suffering from certain Sac

      11/13/24 4:05:00 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • Tenon Medical Announces Initial Clinical Cases Successfully Completed with Company's New Catamaran(R) SE SI Joint Fusion System

      ~ Procedures Completed in Various Spine & Pain Centers of Excellence Throughout the Country Including in Idaho, Pennsylvania, Minnesota, Arizona and Utah ~~Feedback From Initial Physician Users to Support Broader Market Introduction~ LOS GATOS, CA / ACCESSWIRE / October 30, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced completion of the initial clinical cases utilizing the Company's new Catamaran SE SI Joint Fixation Device. The new implant offers a 30% reduction in implant width as compared to the original Catamaran Fixation Device, providing physicians wi

      10/30/24 4:05:00 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care

    $TNON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Williamson Kevin

      3 - Tenon Medical, Inc. (0001560293) (Issuer)

      9/19/24 6:52:57 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • SEC Form 3 filed by new insider Jacques Kristine M

      3 - Tenon Medical, Inc. (0001560293) (Issuer)

      3/29/24 5:41:26 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • Van Dick Steven M converted options into 1,522 shares, increasing direct ownership by 15% to 11,565 units (SEC Form 5)

      5 - Tenon Medical, Inc. (0001560293) (Issuer)

      2/13/24 4:48:49 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care

    $TNON
    SEC Filings

    See more
    • SEC Form 10-Q filed by Tenon Medical Inc.

      10-Q - Tenon Medical, Inc. (0001560293) (Filer)

      5/13/25 4:50:30 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • SEC Form 424B3 filed by Tenon Medical Inc.

      424B3 - Tenon Medical, Inc. (0001560293) (Filer)

      4/16/25 4:00:27 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • SEC Form EFFECT filed by Tenon Medical Inc.

      EFFECT - Tenon Medical, Inc. (0001560293) (Filer)

      4/16/25 12:15:20 AM ET
      $TNON
      Medical/Dental Instruments
      Health Care

    $TNON
    Leadership Updates

    Live Leadership Updates

    See more
    • Tenon Medical Appoints Medical Device Veteran, Kevin Williamson, Chief Financial Officer

      LOS GATOS, CA / ACCESSWIRE / August 27, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced it has appointed Kevin Williamson as Chief Financial Officer. Mr. Williamson's appointment succeeds the previously disclosed retirement of Steve Van Dick from the role of Chief Financial Officer.Mr. Williamson most recently served as the Chief Financial Officer at Accelus Inc., a medical device company focused on expandable spinal implant technology. In this role, Mr. Williamson was responsible for the finance organization, in addition to the investor relation

      8/27/24 4:05:00 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • Tenon(R) Medical Appoints Kristine Jacques to its Board of Directors

      Experienced Medical Devices Industry Executive Joins Tenon's Board of DirectorsLOS GATOS, CA / ACCESSWIRE / March 28, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint disorders, today announced that Kristine Jacques has been appointed as an independent member of the Company's Board of Directors on March 25, 2024, effective immediately. Following this appointment, Tenon Medical's Board of Directors consists of seven members, including four independent directors.During her impressive career spanning over 35 years, Ms. Jacques brings extensive experience in various executive leadership roles in

      3/28/24 8:00:00 AM ET
      $TNON
      Medical/Dental Instruments
      Health Care

    $TNON
    Financials

    Live finance-specific insights

    See more
    • Tenon Medical, Inc. Announces Timing of Third Quarter 2024 Financial Results

      LOS GATOS, CA / ACCESSWIRE / October 30, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced plans to release financial results for the third quarter 2024 ended September 30, 2024 after market close on Wednesday, November 13, 2024. The Company will also hold a conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.Date:Wednesday, November 13, 2024Time:4:30 p.m. Eastern timeDial-in:1-800-717-1738International Dial-in:1-646-307-1865Webcast:TNON C

      10/30/24 8:00:00 AM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • Tenon Medical Reports Second Quarter 2024 Financial Results

      ~ Second Quarter 2024 Revenue Increased 21% Year-Over-Year ~~ Surgical Procedures Increased 7% Year-Over-Year in the Second Quarter 2024 ~~ Gross Profit Margin of 52% Marks One Year of Generating Positive Gross Profit ~~ Publication of Post-Market Study Interim Analysis Now Imminent ~ LOS GATOS, CA / ACCESSWIRE / August 13, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today reported financial results for the second quarter ended June 30, 2024.Second Quarter 2024 and Subsequent HighlightsRevenue of $901,000 in the second quarter of 2024, a 21% increase over th

      8/13/24 4:05:00 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • Tenon Medical, Inc. Announces Timing of Second Quarter 2024 Financial Results

      LOS GATOS, CA / ACCESSWIRE / July 30, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced plans to release financial results for the second quarter 2024 ended June 30, 2024 after market close on Tuesday, August 13, 2024. The Company will also hold a conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.Date:Tuesday, August 13, 2024Time:4:30 p.m. Eastern timeDial-in:1-877-407-0792International Dial-in:1-201-689-8263Webcast:TNON Conference

      7/30/24 8:00:00 AM ET
      $TNON
      Medical/Dental Instruments
      Health Care

    $TNON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Tenon Medical Inc.

      SC 13G - Tenon Medical, Inc. (0001560293) (Subject)

      10/4/24 1:21:56 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by Tenon Medical Inc.

      SC 13G - Tenon Medical, Inc. (0001560293) (Subject)

      8/8/24 4:07:29 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Tenon Medical Inc.

      SC 13G/A - Tenon Medical, Inc. (0001560293) (Subject)

      8/8/24 4:02:25 PM ET
      $TNON
      Medical/Dental Instruments
      Health Care